Nemolizumab is safe and effective for long-term use in patients with moderate-to-severe atopic dermatitis, an extension study ...

In a retrospective analysis of 151 cases, low level laser therapy achieved the highest satisfaction and perceived ...

The NIAGARA trial showed that adding durvalumab to neoadjuvant chemotherapy in MIBC patients did not negatively impact HRQOL outcomes. Significant improvement in event-free survival was observed with ...

Perth-based biotech Argenica Therapeutics, which is developing treatments to reduce brain tissue death after stroke, plans to ...

A one-time gene-editing therapy, exagamglogene autotemcel (exa-cel), has demonstrated sustained and clinically meaningful ...

A new study published in the journal of BMC Surgery revealed that far lateral lumbar disc herniation (FLLDH) presents diagnostic and surgical challenges, but unilateral biportal ...

Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...

Among patients with metastatic cancer who are receiving oral targeted therapy, home-based supervised physical therapy has ...

Weekly hydrocolloid dressings were comparable to a daily petroleum-based regimen for patient-reported scar appearance after ...

Background The minimally important difference (MID) for frailty variation associated with adverse outcomes remains unknown in ...

Waste Management, Inc. (NYSE: WM) is included among the 12 Most Promising Dividend Stocks According to Wall Street Analysts.